Bruker Corporation (BRKR)
| Market Cap | 7.42B |
| Revenue (ttm) | 3.44B |
| Net Income (ttm) | -23.70M |
| Shares Out | 151.94M |
| EPS (ttm) | -0.16 |
| PE Ratio | n/a |
| Forward PE | 24.38 |
| Dividend | $0.20 (0.41%) |
| Ex-Dividend Date | Dec 8, 2025 |
| Volume | 1,048,523 |
| Open | 49.10 |
| Previous Close | 49.03 |
| Day's Range | 48.56 - 49.10 |
| 52-Week Range | 28.53 - 64.64 |
| Beta | 1.20 |
| Analysts | Buy |
| Price Target | 45.67 (-6.43%) |
| Earnings Date | Nov 3, 2025 |
About BRKR
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science... [Read more]
Financial Performance
In 2024, Bruker's revenue was $3.37 billion, an increase of 13.56% compared to the previous year's $2.96 billion. Earnings were $113.10 million, a decrease of -73.53%.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price target is $45.67, which is a decrease of -6.43% from the latest price.
News
Indaba Capital Announces Sale of AST Revolution to Bruker
SAN FRANCISCO--(BUSINESS WIRE)--Indaba Capital Management, L.P. (“Indaba”), controlling shareholder of AST Revolution, LLC (“AST Revolution” or the “Company”), today announced the sale of AST Revoluti...
Q3 2025 Portfolio: Focusing On Resilience, Attractive Valuation And Sound Capital Allocation
GOOG was a top performer following strong core business results and the accelerated adoption of its AI offerings. TEL was a top performer as it is benefiting from AI spending plus delivering stronger ...
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors (“Board”) has approved payment of a quarterly cash dividend in t...
Why Bruker Stock Slumped Monday
It flipped to a GAAP net loss in its third quarter, although on a non-GAAP basis it was in the black. It beat on both the top and bottom lines.
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
Massachusetts-based Lane Generational sold 87,607 shares of Bruker for an estimated $3.6 million in the third quarter. The transaction value represented 3% of 13F reportable assets under management.
Bruker Corporation (BRKR) Q3 2025 Earnings Call Transcript
Bruker Corporation ( BRKR) Q3 2025 Earnings Call November 3, 2025 8:30 AM EST Company Participants Joe Kostka Frank Laukien - Chairman, CEO & President Gerald Herman - Executive VP & CFO Conference C...
Bruker Reports Third Quarter 2025 Financial Results
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and nine months ended September 30, 2025. Frank H. Laukien, Bruker'...
Bruker Announces Date and Time of Third Quarter 2025 Earnings Release and Webcast
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2025 financial results before market opening on Monday, November 3, 20...
Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwestern University
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced new orders for advanced Nuclear Magnetic Resonance (NMR) instrumentation from the New York Structur...
New Preferred Stock And Baby Bond IPOs, September 2025
Six new preferred stock and baby bond offerings were tracked, with yields ranging from 6.375% to 8.875%. Top-quality preferreds (Compliance Score 10) are trading at a 2.8% discount to par, offering a ...
BRUKP: Bruker Corp 6.375% Mandatory Convertible Preferred Stock IPO
Bruker Corporation 6.375 PREF SER A is a new 6.375% mandatory convertible preferred stock from Bruker, offering fixed income but closely tied to BRKR's common stock performance. Bruker's fundamentals ...
Why Bruker Stock Tumbled by Almost 12% Wednesday
Medical device and diagnostics company Bruker (BRKR -11.68%) wasn't looking like the cure for any investor's ailments on Wednesday. The stock was hit with an assertive sell-off from the market, leavin...
Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced the pricing of its previously announced public offering of $600.0 million of 6.375% Mand...
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining around 150 points on Wednesday.
Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced it has commenced a public offering, subject to market and other conditions, of $600.0 mi...
Bruker: Former Academia Customer Strength, Now Incredible Weakness
Bruker faces significant headwinds due to NIH funding cuts, heavy reliance on academia, and declining financial performance versus peers. Despite operational challenges and a sharp drop in valuation, ...
Bruker Announces Quarterly Dividend
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.0...
Bruker Secures Multi-Year Contracts for Explosives and Chemical Trace Detection in Aviation and Defense Sectors
ETTLINGEN, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the signing of multiple new contracts and framework agreements for its explosives and chemical tr...
These Analysts Slash Their Forecasts On Bruker After Weaker-Than-Expected Q2 Results
Bruker Corporation BRKR reported worse-than-expected second-quarter financial results and cut its FY25 guidance on Monday.
Bruker Stock: Caution Warranted Despite Bullish Analyst Calls
Bruker Corporation BRKR is currently in the 17th phase of its 18-phase Adhishthana cycle on the weekly chart and signals point to potential trouble ahead. While several large financial institutions re...
Bruker Corporation (BRKR) Q2 2025 Earnings Call Transcript
Bruker Corporation (NASDAQ:BRKR) Q2 2025 Earnings Conference Call August 4, 2025 8:30 AM ET Company Participants Frank H. Laukien - Chairman, CEO & President Gerald N.
Bruker (BRKR) Q2 Revenue Slips 0.4%
Bruker (BRKR) Q2 Revenue Slips 0.4%
Bruker Reports Second Quarter 2025 Financial Results
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2025. Frank H. Lauki...
Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the second quarter ended June 30, 2025 in a range of $795 - $798 million, w...
Bruker Experiences Growth in Semiconductor Advanced Packaging Market Fueled by AI Demands
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the shipment and installation of the 15th InSight WLI 3D optical metrology system to a leading semi...